Piperlongumine Inhibits the Growth of Non-small Cell Lung Cancer Cells Via the MiR-34b-3p/TGFBR1 Pathway

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2021 Jan 8

PMID 33413277

Citations 8

Authors

Xinhua Lu

Chenyang Xu

Zhexuan Xu

Chunya Lu

Rui Yang

Furui Zhang

Guojun Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Non-small cell lung cancer is a common type of lung cancer. Piperlongumine (PL), which is extracted from the roots of piperaceae plant, long pepper, and peppercorn, is an alkaloid amide that inhibits tumor growth and metastasis. However, whether it affects lung cancer cells remains unclear.

Methods: We assessed the effects of PL on the proliferation and apoptosis of A549 and H1299 NSCLC cell lines.

Results: PL was mildly toxic to normal human bronchial epithelial cells and significantly suppressed growth and facilitated apoptosis of A549 and H1299 cells. It also upregulated microRNA (miR)-34b-3p and downregulated the transforming growth factor beta type I receptor (TGFBR1). The dual-luciferase reporter assay showed that TGFBR1 is a target gene of miR-34b-3p. Silencing of miR-34b-3p or overexpression of TGFBR1 partially attenuated the effects of PL on A549 and H1299 cells.

Conclusions: PL inhibits proliferation and induces apoptosis of A549 and H1299 cells by upregulating miR-34b-3p and modulating TGFBR1 signaling pathway.

Citing Articles

Advance in identified targets of berberine.

Sun P, Wang Z, Ma Y, Liu Y, Xue Y, Li Y Front Pharmacol. 2025; 16:1500511.

PMID: 39944624 PMC: 11814165. DOI: 10.3389/fphar.2025.1500511.

Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells.

Modi S, Andey T Oncol Res. 2024; 32(11):1709-1721.

PMID: 39449797 PMC: 11497197. DOI: 10.32604/or.2024.053972.

Piperlongumine regulates genes involved in the skin barrier in epidermal keratinocyte HaCaT cells.

Lee K, Kang D, Kim D, Do H, Kim D, Kim W Anim Cells Syst (Seoul). 2024; 28(1):326-339.

PMID: 38933927 PMC: 11207940. DOI: 10.1080/19768354.2024.2361144.

PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer.

Rostami F, Tavakol Hamedani Z, Sadoughi A, Mehrabadi M, Kouhkan F Sci Rep. 2024; 14(1):13542.

PMID: 38866824 PMC: 11169246. DOI: 10.1038/s41598-024-62064-5.

The microRNA-34 Family and Its Functional Role in Lung Cancer.

Zhang T, Hu Y, Yang N, Yu S, Pu X Am J Clin Oncol. 2024; 47(9):448-457.

PMID: 38700126 PMC: 11340685. DOI: 10.1097/COC.0000000000001106.

References

Liu C, Cheng H, Shi S, Cui X, Yang J, Chen L . MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr Mol Med. 2013; 13(4):467-78. DOI: 10.2174/1566524011313040001. View

Yamashita R, Sato M, Kakumu T, Hase T, Yogo N, Maruyama E . Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells. Cancer Med. 2015; 4(4):551-64. PMC: 4402070. DOI: 10.1002/cam4.412. View

Zhou L, Li M, Yu X, Gao F, Li W . Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells. Int J Biol Sci. 2019; 15(4):826-837. PMC: 6429016. DOI: 10.7150/ijbs.31749. View

Zhang W, Chin T, Yang H, Nga M, Lunny D, Lim E . Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016; 7:11702. PMC: 4919505. DOI: 10.1038/ncomms11702. View

Daugaard I, Knudsen A, Kjeldsen T, Hager H, Hansen L . The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma. Exp Mol Pathol. 2017; 102(3):484-491. DOI: 10.1016/j.yexmp.2017.05.012. View

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

Higgins K, Pillai R, Chen Z, Tian S, Zhang C, Patel P . Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study. J Thorac Oncol. 2017; 12(11):1687-1695. DOI: 10.1016/j.jtho.2017.07.036. View

Song X, Gao T, Lei Q, Zhang L, Yao Y, Xiong J . Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption. Nutr Cancer. 2018; 70(3):502-511. DOI: 10.1080/01635581.2018.1445769. View

Mohammad J, Dhillon H, Chikara S, Mamidi S, Sreedasyam A, Chittem K . Piperlongumine potentiates the effects of gemcitabine in and human pancreatic cancer models. Oncotarget. 2018; 9(12):10457-10469. PMC: 5828188. DOI: 10.18632/oncotarget.23623. View

10.

Cheng R, Dang R, Zhou Y, Ding M, Hua H . MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1. Hum Cell. 2017; 30(3):192-200. DOI: 10.1007/s13577-017-0163-0. View

11.

Karki K, Hedrick E, Kasiappan R, Jin U, Safe S . Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. Cancer Prev Res (Phila). 2017; 10(8):467-477. PMC: 6357769. DOI: 10.1158/1940-6207.CAPR-17-0053. View

12.

Wang H, Zhang Q, Wang B, Wu W, Wei J, Li P . miR-22 regulates C2C12 myoblast proliferation and differentiation by targeting TGFBR1. Eur J Cell Biol. 2018; 97(4):257-268. DOI: 10.1016/j.ejcb.2018.03.006. View

13.

Mizuno K, Mataki H, Arai T, Okato A, Kamikawaji K, Kumamoto T . The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. J Hum Genet. 2017; 62(7):671-678. DOI: 10.1038/jhg.2017.27. View

14.

Gu Y, Zhang Z, Yin J, Ye J, Song Y, Liu H . Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1). J Exp Clin Cancer Res. 2017; 36(1):114. PMC: 5580233. DOI: 10.1186/s13046-017-0582-5. View

15.

Roh J, Kim E, Park J, Kim J, Kwon M, Lee B . Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Oncotarget. 2014; 5(19):9227-38. PMC: 4253430. DOI: 10.18632/oncotarget.2402. View

16.

Wang H, Jiang H, Corbet C, de Mey S, Law K, Gevaert T . Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems. Cancer Lett. 2019; 450:42-52. DOI: 10.1016/j.canlet.2019.02.034. View

17.

Wang J, Zeng H, Li H, Chen T, Wang L, Zhang K . MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2. Cell Physiol Biochem. 2017; 43(2):717-732. DOI: 10.1159/000481445. View

18.

Stadhouders R, Vidal E, Serra F, Di Stefano B, Le Dily F, Quilez J . Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming. Nat Genet. 2018; 50(2):238-249. PMC: 5810905. DOI: 10.1038/s41588-017-0030-7. View

19.

Feng H, Ge F, Du L, Zhang Z, Liu D . MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4. J Cell Mol Med. 2019; 23(8):5282-5291. PMC: 6652730. DOI: 10.1111/jcmm.14404. View

20.

Seok J, Jeong C, Petriello M, Seo H, Yoo H, Hong K . Piperlongumine decreases cell proliferation and the expression of cell cycle-associated proteins by inhibiting Akt pathway in human lung cancer cells. Food Chem Toxicol. 2017; 111:9-18. DOI: 10.1016/j.fct.2017.10.058. View